Analysis of MIF, FCGR2A and FCGR3A gene polymorphisms with susceptibility to pulmonary tuberculosis in Moroccan population

Journal of Genetics and Genomics

Volumn 37, Issue 4, 2010, Pages 257-264

  Sadki, Khalid ^a   Lamsyah, Hoda ^a,c   Rueda, Blanca ^b   Akil, ELmahfoud ^a   Sadak, Abderrahim ^c   Martin, Javier ^b   El Aouad, Rajae ^a  

^a INSTITUT NATIONAL D HYGIÈNE   (Morocco)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c FACULTÉ DES SCIENCES   (Morocco)

Author keywords

FCGR; MIF; Moroccan; polymorphism; pulmonary tuberculosis; susceptibility

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIA; FC RECEPTOR IIIA; MACROPHAGE MIGRATION INHIBITION FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOROCCO; MYCOBACTERIUM TUBERCULOSIS; POPULATION GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

DISEASE SUSCEPTIBILITY; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETIC VARIATION; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MOROCCO; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION GROUPS; PROMOTER REGIONS, GENETIC; RECEPTORS, IGG; TUBERCULOSIS, PULMONARY;

EID: 77951521367     PISSN: 16738527     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1673-8527(09)60044-8     Document Type: Article

References (48)

1. Bacher M., Metz C.N., Calandra T., Mayer K., Chesney J., Lohoff M., Gemsa D., Donnelly T., and Bucala R. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl. Acad. Sci. USA 93 (1996) 7849-7854
2. Barton A., Lamb R., Symmons D., Silman A., Thomson W., Worthington1 J., and Donn R. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun. 4 (2003) 487-491
3. Baugh J.A., Chitnis S., Donnelly S.C., Monteiro J., Lin X., Plant B.J., Wolfe F., Gregersen P.K., and Bucala R. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 3 (2002) 170-176
4. Bellamy R. Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun. 4 (2003) 4-11
5. Biezeveld M., Geissler J., Merkus M., Kuipers I.M., Ottenkamp J., and Kuijpers T. The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease. Clin. Exp. Immunol. 147 (2006) 106-111
6. Bloom B.R., and Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153 (1966) 80-82
7. Calandra T. Macrophage migration inhibitory factor and host innate immune responses to microbes. Scand. J. Infect. Dis. 35 (2003) 573-576
8. Casanova J.L., and Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20 (2002) 581-620
9. Dambacher J., Staudinger T., Seiderer J., Sisic Z., Schnitzler F., Pfennig S., Hofbauer K., Konrad A., Tillack C., Otte J.M., Diebold J., Göke B., Ochsenkühn T., Lohse P., and Brand S. Macrophage migration inhibitory factor (MIF) -173G/C Promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with crohn's disease. Inflamm. Bowel Dis. 13 (2007) 71-82
10. David J.R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56 (1966) 72-77
11. de la Fontaine L., Schwarz M.J., Riedel M., Dehning S., Douhet A., Spellmann I., Kleindienst N., Zill P., Plischke H., Gruber R., and Müller N. Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusing on MIF and CD14 gene polymorphisms. Psychiatry Res. 144 (2006) 39-47
12. Deo Y.M., Graziano R.F., Repp R., and van de Winkel J.G. Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies. Immunol. Today 18 (1997) 127-135
13. Dijstelbloem H.M., Scheepers R.H., Oost W.W., Stegeman C.A., van der Pol W.L., Sluiter W.J., Kallenberg C.G., van de Winkel J.G., and Tervaert J.W. Fcgamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse. Arthritis Rheum. 42 (1999) 1823-1827
14. Domingo P., Muñiz-Diaz E., Baraldès M.A., Arilla M., Barquet N., Pericas R., Juárez C., Madoz P., and Vázquez G. Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. Am. J. Med. 112 (2002) 19-25
15. Donn R., Alourfi Z., and De Benedetti F. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 46 (2002) 2402-2409
16. Fijen C.A.P., Bredius R.G.M., and Kuijper E.J. Polymorphism of IgG Fc receptors in meningococcal disease. Ann. Intern. Med. 119 (1993) 636
17. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19 (2001) 93-129
18. Gómez L.M., Sánchez E., Ruiz-Narvaez E.A., Lopez-Nevot M.A., Anaya J.M., and Martin J. Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population. Tissue Antigens 70 (2007) 28-33
19. Jepson A., Fowler A., Banya W., Singh M., Bennett S., Whittle H., and Hill A.V. Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa. Infect. Immun. 69 (2001) 3989-3994
20. Juttner S., Bernhagen J., Metz C.N., Rollinghoff M., Bucala R., and Gessner A. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J. Immunol. 161 (1998) 2383-2390
21. Kaufmann S.H. How can immunology contribute to the control of tuberculosis?. Nat. Rev. Immunol. 1 (2001) 20-30
22. Koebernick H., Grode L., David J.R., Rohde W., Rolph M.S., Mittrücker H.W., and Kaufmann S.H. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 99 (2002) 13681-13686
23. Koene H.R., Kleijer M., Algra J., von Roos D., dem Borne A.E., and de Haas M. Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood 90 (1997) 1109-1114
24. Maglione P.J., Xu J., Casadevall A., and Chan J. Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection. J. Immunol. 180 (2008) 3329-3338
25. Martínez A., Orozco G., Varadé J., López M.S., Pascual D., Balsa A., García A., de la Concha E.G., Fernández-Gutiérrez B., Martín J., and Urcelay E. Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility. Hum. Immunol. 68 (2007) 744-747
26. Maxwell K.F., Powell M.S., Hulett M.D., Barton P.A., McKenzie I.F., Garrett T.P., and Hogarth P.M. Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat. Struct. Biol. 6 (1999) 437-442
27. Mitchell R.A., Liao H., Chesney J., Fingerle-Rowson G., Baugh J., and David J. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. USA 99 (2002) 345-350
28. Mitchell R.A., Metz C.N., Peng T., and Bucala R. Sustained mitogenactivated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF): regulatory role in cell proliferation and glucocorticoid action. J. Biol. Chem. 274 (1999) 18100-18106
29. Morgan A.W., Robinson J.I., Barrett J.H., Martin J., Walker A., Babbage S.J., Ollier W.E., Gonzalez-Gay M.A., and Isaacs J.D. Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis. Arthritis Res. Ther. 8 4 (2006) R109
30. Musser J.M., Kroll J.S., Granoff D.M., Moxon E.R., Brodeur B.R., Campos J., Dabernat H., Frederikson W., Hamel J., and Hammond G. Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev. Infect. Dis. 12 (1990) 75-111
31. Oddo M., Calandra T., Bucala R., and Meylan P.R.A. Macrophage migration inhibitory factor reduces the growth of virulent Mycobacterium tuberculosis in human macrophages. Infect. Immun. 73 (2005) 3783-3786
32. Oliver J., Márquez A., Gómez-Garcia M., Martinez A., Mendoza J.L., Vilchez J.R., López-Nevot M.A., Piñero A., de la Concha E.G., Nieto A., Urcelay E., and Martín J. Association of macrophage inhibitory factor gene polymorphism with inflammatory bowel disease. Gut 56 (2007) 150-151
33. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J.K., Singh Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., Waal-Malefyt R., Hannum C., Bazan J.F., and Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 (2000) 715-725
34. Parren P.W., Warmerdam P.A., Boeije L.C., Arts J., Westerdaal N.A., Vlug A., Capel P.J., Aarden L.A., and van de Winkel J.G. On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J. Clin. Invest. 90 (1992) 1537-1546
35. Peltz G.A., Grundy H.O., Lebo R.V., Yssel H., Barsh G.S., and Moore K.W. Human Fc gamma RIII: cloning, expression, and identification of the chromosomal locus of two Fc receptors for IgG. Proc. Natl. Acad. Sci. USA 86 (1989) 1013-1017
36. Plant B.J., Gallagher C.G., Bucala R., Baugh J.A., Chappell S., Morgan L., O'Connor C.M., Morgan K., and Donnelly S.C. Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism. Am. J. Respir. Crit. Care Med. 172 (2005) 1412-1415
37. Qiu W.Q., de Bruin D., Brownstein B.H., Pearse R., and Ravetch J.V. Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination. Science 248 (1990) 732-735
38. Ravetch J.V., and Bolland S. IgG Fc receptors. Annu. Rev. Immunol. 19 (2001) 275-290
39. Renner P., Roger T., and Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin. Infect. Dis. 41 Suppl7 (2005) S513
40. Roger T., David J., Glauser M.P., and Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414 (2001) 920-924
41. Roger T., Glauser M.P., and Calandra T. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria. J. Endotoxin. Res. 7 (2001) 456-460
42. Sánchez E., Gómez L.M., Lopez-Nevot M.A., González-Gay M.A., Sabio J.M., Ortego-Centeno N., de Ramón E., Anaya J.M., González-Escribano M.F., Koeleman B.P., and Martín J. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun. 7 (2006) 433-436
43. Satoskar A.R., Bozza M., Rodriguez Sosa M., Lin G., and David J.R. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect. Immun. 69 (2001) 906-911
44. Temple S.E., Cheong K.Y., Price P., and Waterer G.W. The microsatellite, macrophage migration inhibitory factor -794, may influence gene expression in human mononuclear cells stimulated with E. coli or S. pneumoniae. Int. J. Immunogenet. 35 (2008) 309-316
45. Tohyama S., Onodera S., Tohyama H., Yasuda K., Nishihira J., Mizue Y., Hamasaka A., Abe R., and Koyama Y. A novel DNA vaccine-targeting macrophage migration inhibitory factor improves the survival of mice with sepsis. Gene Ther. 15 (2008) 1513-1522
46. Van Crevel R., Ottenhoff T.H., and van der Meer J.W. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15 (2002) 294-309
47. Yamada G., Shijubo N., Takagi-Takahashi Y.N.J., Mizue Y., Kikuchi K., and Abe S. Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis. Clin. Immunol. 104 (2002) 123-127
48. Warmerdam P.A., van de Winkel J.G., Vlug A., Westerdaal N.A., and Capel P.J. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J. Immunol. 147 (1991) 1338-1343